GlassScriptPhysician profile
Jessy Diaz
NPI 1487955902
$2,459.68
in general payments reported to CMS, 2019-2025
21 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $619 · 2022: $337 · 2023: $366 · 2024: $591 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.41 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $560.19 | 2023-2025 | |
| Allergan, INC. | $477.45 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $271.60 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $267.85 | 2022-2024 | Tremfya, Simponi, Simponi Aria |
| Organogenesis INC. | $127.33 | 2021-2025 | Cygnus Dual |
| Novartis Pharmaceuticals Corporation | $109.06 | 2021-2025 | |
| Ucb, INC. | $84.94 | 2021-2025 | Bimzelx |
| Incyte Corporation | $75.68 | 2022-2025 | Opzelura |
| Almirall LLC | $65.81 | 2022-2024 | Klisyri |
| Arcutis Biotherapeutics, INC. | $60.84 | 2023-2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.98 | 2024-2025 | Spevigo |
| Pfizer INC. | $50.37 | 2021-2022 | |
| Hill Dermaceuticals, INC. | $48.95 | 2025 | Tolak |
| Mayne Pharma Commercial LLC | $42.10 | 2023-2025 | |
| Galderma Laboratories, L.P. | $40.41 | 2024-2025 | Aklief |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.82 | 2021 | |
| Journey Medical Corporation | $24.59 | 2025 | |
| Genzyme Corporation | $24.50 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.21 | 2021 | |
| Lilly USA, LLC | $16.75 | 2021 | |
| Organon LLC | $5.25 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessy Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.